These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2450966)

  • 21. Biochemistry and immunology of infectious bursal disease virus.
    Kibenge FS; Dhillon AS; Russell RG
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1757-75. PubMed ID: 2841403
    [No Abstract]   [Full Text] [Related]  

  • 22. Limited antigenic variation among recent infectious bursal disease virus isolates from France.
    Eterradossi N; Rivallan G; Toquin D; Guittet M
    Arch Virol; 1997; 142(10):2079-87. PubMed ID: 9413517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective immune responses of recombinant VP2 subunit antigen of infectious bursal disease virus in chickens.
    Pradhan SN; Prince PR; Madhumathi J; Roy P; Narayanan RB; Antony U
    Vet Immunol Immunopathol; 2012 Aug; 148(3-4):293-301. PubMed ID: 22795186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological roles of the major capsid proteins and relationships between the two existing serotypes of infectious bursal disease virus.
    Reddy SK; Silim A; Ratcliffe MJ
    Arch Virol; 1992; 127(1-4):209-22. PubMed ID: 1333752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Identification of VP3 antigenic epitopes of infectious bursal disease virus].
    Deng XY; Gao YL; Gao HL; Qi XL; Wang XY; Wang XM
    Bing Du Xue Bao; 2007 Jul; 23(4):305-11. PubMed ID: 17894234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of standard and variant strains of infectious bursal disease virus on infections of chickens.
    Craft DW; Brown J; Lukert PD
    Am J Vet Res; 1990 Aug; 51(8):1192-7. PubMed ID: 2167031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibody analysis of serotype-restricted and unrestricted bluetongue viral antigenic determinants.
    Appleton JA; Letchworth GJ
    Virology; 1983 Jan; 124(2):286-99. PubMed ID: 6186076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of crucial residues of conformational epitopes on VP2 protein of infectious bursal disease virus by phage display.
    Cui X; Nagesha HS; Holmes IH
    J Virol Methods; 2003 Apr; 109(1):75-83. PubMed ID: 12668271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
    Orvell C; Norrby E; Mufson MA
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic relationship of non-serotype 1 turkey infectious bursal disease viruses from the United States and United Kingdom.
    McNulty MS; Saif YM
    Avian Dis; 1988; 32(2):374-5. PubMed ID: 2840886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of serotype-specific neutralization epitopes on VP7 of human rotavirus by the use of neutralizing monoclonal antibodies and antigenic variants.
    Morita Y; Taniguchi K; Urasawa T; Urasawa S
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():451-8. PubMed ID: 2448418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of precipitin antibodies and virus-neutralizing antibodies to infectious bursal disease virus.
    Phillips WE
    Avian Dis; 1981; 25(4):1093-7. PubMed ID: 6279066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-idiotypic antibody specific for an infectious bursal disease virus-neutralizing monoclonal antibody does not interfere with the virus infection.
    Yamaguchi T; Igusa A; Setiyono A; Fukushi H; Hirai K
    Arch Virol; 2002 Oct; 147(10):2017-23. PubMed ID: 12376762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of virus neutralizing and precipitating antibodies to infectious bursal disease virus and their effect on susceptibility to challenge.
    Chettle NJ; Eddy RK; Wyeth PJ
    Br Vet J; 1985; 141(2):146-50. PubMed ID: 2986756
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of a neutralizing epitope shared by bluetongue virus serotypes 2 and 13.
    Ristow S; Leendersten L; Gorham J; Yilma T
    J Virol; 1988 Jul; 62(7):2502-4. PubMed ID: 2453681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modified activity of a VP2-located neutralizing epitope on various vaccine, pathogenic and hypervirulent strains of infectious bursal disease virus.
    Eterradossi N; Toquin D; Rivallan G; Guittet M
    Arch Virol; 1997; 142(2):255-70. PubMed ID: 9125042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression in Escherichia coli of cDNA fragments encoding the gene for the host-protective antigen of infectious bursal disease virus.
    Azad AA; Fahey KJ; Barrett SA; Erny KM; Hudson PJ
    Virology; 1986 Mar; 149(2):190-8. PubMed ID: 3004025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on antigenic relatedness of classic and variant strains of infectious bursal disease viruses.
    Ture O; Tsai HJ; Saif YM
    Avian Dis; 1993; 37(3):647-54. PubMed ID: 8257353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenic diversity of infectious bursal disease viruses.
    Jackwood DH; Saif YM
    Avian Dis; 1987; 31(4):766-70. PubMed ID: 2831868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serologic evidence of infectious bursal disease virus infection in Iowa turkeys.
    Barnes HJ; Wheeler J; Reed D
    Avian Dis; 1982; 26(3):560-65. PubMed ID: 6184043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.